CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 533 shares (grant or award)
- 4 Grant or award Director acquired 825 shares (grant or award)
- 4 Grant or award Director acquired 517 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 8,000 shares at $38.93 ($311,440)
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 339,800 shares at an average $49.53 ($16,830,151)
- 4 Planned sale President sold 9,692 shares at $52.00 ($503,984)
- 144 Insider Sale of Securities
- 4 Planned sale President sold 9,692 shares at $42.30 ($410,019)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 7 of 14 · 267 filings